Francois Anna

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Optimized pipeline for generating highly potent neutralizing Affitins: Application to SARS-CoV-2 spike protein.

Optimized pipeline for generating highly potent neutralizing Affitins: Application to SARS-CoV-2 spike protein.

Journal: International journal of biological macromolecules

Published: May 02, 2025

Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.

Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.

Journal: NPJ vaccines

Published: February 21, 2025

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

Journal: NPJ vaccines

Published: November 30, 2023

Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Journal: Cancer immunology research

Published: July 10, 2023

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Journal: EMBO molecular medicine

Published: March 20, 2023

Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.

Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.

Journal: Pharmaceutics

Published: February 08, 2023

Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.

Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.

Journal: Microbes and infection

Published: December 29, 2022

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters.

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters.

Journal: Vaccines

Published: November 11, 2022

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

Journal: Annals of the rheumatic diseases

Published: March 26, 2022

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 13, 2022

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

Journal: Mucosal immunology

Published: October 21, 2021

Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.

Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.

Journal: Frontiers in immunology

Published: October 06, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026